Annual Cash & Cash Equivalents
$10.72 M
-$31.07 M-74.35%
December 1, 2024
Summary
- As of February 25, 2025, GLYC annual cash & cash equivalents is $10.72 million, with the most recent change of -$31.07 million (-74.35%) on December 1, 2024.
- During the last 3 years, GLYC annual cash & cash equivalents has fallen by -$79.53 million (-88.12%).
- GLYC annual cash & cash equivalents is now -94.89% below its all-time high of $209.92 million, reached on December 31, 2018.
Performance
GLYC Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$10.72 M
-$3.67 M-25.51%
December 1, 2024
Summary
- As of February 25, 2025, GLYC quarterly cash and cash equivalents is $10.72 million, with the most recent change of -$3.67 million (-25.51%) on December 1, 2024.
- Over the past year, GLYC quarterly cash and cash equivalents has dropped by -$3.67 million (-25.51%).
- GLYC quarterly cash and cash equivalents is now -95.58% below its all-time high of $242.63 million, reached on March 31, 2018.
Performance
GLYC Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
GLYC Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -74.3% | -25.5% |
| 3 y3 years | -88.1% | -25.5% |
| 5 y5 years | -93.2% | -25.5% |
GLYC Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -88.1% | at low | -88.1% | at low |
| 5 y | 5-year | -93.2% | at low | -93.2% | at low |
| alltime | all time | -94.9% | +364.0% | -95.6% | +364.0% |
GlycoMimetics Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $10.72 M(-74.3%) | $10.72 M(-25.5%) |
| Sep 2024 | - | $14.39 M(-35.7%) |
| Jun 2024 | - | $22.39 M(-28.4%) |
| Mar 2024 | - | $31.28 M(-25.2%) |
| Dec 2023 | $41.79 M(-12.7%) | $41.79 M(-15.4%) |
| Sep 2023 | - | $49.41 M(-14.9%) |
| Jun 2023 | - | $58.04 M(-10.7%) |
| Mar 2023 | - | $65.00 M(+35.8%) |
| Dec 2022 | $47.87 M(-47.0%) | $47.87 M(-7.3%) |
| Sep 2022 | - | $51.62 M(-14.3%) |
| Jun 2022 | - | $60.24 M(-21.3%) |
| Mar 2022 | - | $76.52 M(-15.2%) |
| Dec 2021 | $90.25 M(-34.1%) | $90.25 M(-11.4%) |
| Sep 2021 | - | $101.92 M(-14.2%) |
| Jun 2021 | - | $118.85 M(-10.3%) |
| Mar 2021 | - | $132.47 M(-3.3%) |
| Dec 2020 | $137.03 M(-13.4%) | $137.03 M(-4.1%) |
| Sep 2020 | - | $142.87 M(-4.7%) |
| Jun 2020 | - | $149.84 M(-3.2%) |
| Mar 2020 | - | $154.82 M(-2.1%) |
| Dec 2019 | $158.20 M(-24.6%) | $158.20 M(-7.4%) |
| Sep 2019 | - | $170.89 M(-7.2%) |
| Jun 2019 | - | $184.17 M(-5.8%) |
| Mar 2019 | - | $195.56 M(-6.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2018 | $209.92 M(+69.4%) | $209.92 M(-4.5%) |
| Sep 2018 | - | $219.83 M(-4.2%) |
| Jun 2018 | - | $229.43 M(-5.4%) |
| Mar 2018 | - | $242.63 M(+95.8%) |
| Dec 2017 | $123.92 M(+209.5%) | $123.92 M(+9.8%) |
| Sep 2017 | - | $112.87 M(-5.3%) |
| Jun 2017 | - | $119.15 M(+244.5%) |
| Mar 2017 | - | $34.59 M(-13.6%) |
| Dec 2016 | $40.04 M(-14.4%) | $40.04 M(-11.6%) |
| Sep 2016 | - | $45.28 M(-14.7%) |
| Jun 2016 | - | $53.09 M(+36.7%) |
| Mar 2016 | - | $38.83 M(-17.0%) |
| Dec 2015 | $46.80 M(-15.2%) | $46.80 M(-12.9%) |
| Sep 2015 | - | $53.76 M(+33.6%) |
| Jun 2015 | - | $40.23 M(-13.6%) |
| Mar 2015 | - | $46.57 M(-15.6%) |
| Dec 2014 | $55.20 M(+2288.9%) | $55.20 M(-10.0%) |
| Sep 2014 | - | $61.36 M(-7.3%) |
| Jun 2014 | - | $66.22 M(+16.2%) |
| Mar 2014 | - | $56.97 M(+2365.4%) |
| Dec 2013 | $2.31 M(-86.7%) | $2.31 M(-70.0%) |
| Sep 2013 | - | $7.69 M(-28.7%) |
| Jun 2013 | - | $10.78 M(-38.0%) |
| Dec 2012 | $17.37 M(-38.3%) | $17.37 M |
| Dec 2011 | $28.17 M | - |
FAQ
- What is GlycoMimetics annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for GlycoMimetics?
- What is GlycoMimetics annual cash & cash equivalents year-on-year change?
- What is GlycoMimetics quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for GlycoMimetics?
- What is GlycoMimetics quarterly cash and cash equivalents year-on-year change?
What is GlycoMimetics annual cash & cash equivalents?
The current annual cash & cash equivalents of GLYC is $10.72 M
What is the all time high annual cash & cash equivalents for GlycoMimetics?
GlycoMimetics all-time high annual cash & cash equivalents is $209.92 M
What is GlycoMimetics annual cash & cash equivalents year-on-year change?
Over the past year, GLYC annual cash & cash equivalents has changed by -$31.07 M (-74.35%)
What is GlycoMimetics quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of GLYC is $10.72 M
What is the all time high quarterly cash and cash equivalents for GlycoMimetics?
GlycoMimetics all-time high quarterly cash and cash equivalents is $242.63 M
What is GlycoMimetics quarterly cash and cash equivalents year-on-year change?
Over the past year, GLYC quarterly cash and cash equivalents has changed by -$3.67 M (-25.51%)